Attached files
| file | filename |
|---|---|
| EX-10.1 - EX-10.1 - IGM Biosciences, Inc. | igms-ex101_89.htm |
| EX-31.1 - EX-31.1 - IGM Biosciences, Inc. | igms-ex311_8.htm |
| EX-31.2 - EX-31.2 - IGM Biosciences, Inc. | igms-ex312_7.htm |
| 10-Q - 10-Q - IGM Biosciences, Inc. | igms-10q_20200930.htm |
| EX-10.2 - EX-10.2 - IGM Biosciences, Inc. | igms-ex102_90.htm |
| EX-32.2 - EX-32.2 - IGM Biosciences, Inc. | igms-ex322_9.htm |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of IGM Biosciences, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Fred Schwarzer, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: November 5, 2020 |
|
By: |
/s/ Fred Schwarzer |
|
|
|
|
Fred Schwarzer |
|
|
|
|
Chief Executive Officer and President (Principal Executive Officer) |